1 | Abatacept (ABA) + Methotrexate (MTX), double-blind (DB) (Otrexup (TN)) | 2件: Abatacept Abatacept, Methotrexate (Otrexup) | 2件: Methotrexate
Methotrexate
(Otrexup (TN)),
Abatacept
💬 | 4件: CD80 CD80, CD86, DHFR, DHFR2 💬 | 18件: Allograft rejection Allograft rejection, Antifolate resistance, Autoimmune thyroid disease, Biosynthesis of cofactors, Cell adhesion molecules, Folate biosynthesis, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Metabolic pathways, One carbon pool by folate, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬 | 1件: 46 46 💬 |
2 | Abatacept + Methotrexate (Otrexup (TN)) | 2件: Abatacept Abatacept, Methotrexate (Otrexup) | 2件: Methotrexate
Methotrexate
(Otrexup (TN)),
Abatacept
💬 | 4件: CD80 CD80, CD86, DHFR, DHFR2 💬 | 18件: Allograft rejection Allograft rejection, Antifolate resistance, Autoimmune thyroid disease, Biosynthesis of cofactors, Cell adhesion molecules, Folate biosynthesis, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Metabolic pathways, One carbon pool by folate, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬 | 1件: 46 46 💬 |
3 | Adalimumab 40 mg sc every other week | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬 | 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 271 271 💬 |
4 | Adalimumab 40 mg subcutaneous (SC) every other week (EOW) | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬 | 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 💬 |
5 | Adalimumab with methotrexate (Otrexup (TN)) | 2件: Adalimumab Adalimumab, Methotrexate (Otrexup) | 2件: Methotrexate
Methotrexate
(Otrexup (TN)),
Adalimumab
💬 | 3件: DHFR DHFR, DHFR2, TNF 💬 | 71件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Metabolic pathways, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 💬 |
6 | Allo-APZ2-OTS | - | - | - | - | 1件: 36 36 💬 |
7 | Any other approved Antiepileptic Drug | - | - | - | - | 1件: 144 144 💬 |
8 | Apply VEREGEN ® 10 % on a randomized area and the moisturizing cream of the other side | 1件: Sinecatechins Sinecatechins | 1件: Sinecatechins
Sinecatechins
💬 | - | - | 1件: 160 160 💬 |
9 | Apremilast (Otezla (TN)) | 1件: Apremilast Apremilast (Otezla) | 1件: Apremilast
Apremilast
(Otezla (TN)) 💬 | 4件: PDE4A PDE4A, PDE4B, PDE4C, PDE4D 💬 | 5件: Metabolic pathways Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬 | 7件: 46 46, 50, 56, 97, 107, 162, 271 💬 |
10 | Apremilast (CC-10004) (Otezla (TN)) | 1件: Apremilast Apremilast (Otezla) | 1件: Apremilast
Apremilast
(Otezla (TN)) 💬 | 4件: PDE4A PDE4A, PDE4B, PDE4C, PDE4D 💬 | 5件: Metabolic pathways Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬 | 1件: 56 56 💬 |
11 | Apremilast 10 mg (Otezla (TN)) | 1件: Apremilast Apremilast (Otezla) | 1件: Apremilast
Apremilast
(Otezla (TN)) 💬 | 4件: PDE4A PDE4A, PDE4B, PDE4C, PDE4D 💬 | 5件: Metabolic pathways Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬 | 2件: 56 56, 107 💬 |
12 | Apremilast 20 mg (Otezla (TN)) | 1件: Apremilast Apremilast (Otezla) | 1件: Apremilast
Apremilast
(Otezla (TN)) 💬 | 4件: PDE4A PDE4A, PDE4B, PDE4C, PDE4D 💬 | 5件: Metabolic pathways Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬 | 3件: 46 46, 56, 107 💬 |
13 | Apremilast 30 mg (Otezla (TN)) | 1件: Apremilast Apremilast (Otezla) | 1件: Apremilast
Apremilast
(Otezla (TN)) 💬 | 4件: PDE4A PDE4A, PDE4B, PDE4C, PDE4D 💬 | 5件: Metabolic pathways Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬 | 3件: 46 46, 56, 107 💬 |
14 | Apremilast 30mg (Otezla (TN)) | 1件: Apremilast Apremilast (Otezla) | 1件: Apremilast
Apremilast
(Otezla (TN)) 💬 | 4件: PDE4A PDE4A, PDE4B, PDE4C, PDE4D 💬 | 5件: Metabolic pathways Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬 | 1件: 50 50 💬 |
15 | Apremilast tablet 20 mg (Otezla (TN)) | 1件: Apremilast Apremilast (Otezla) | 1件: Apremilast
Apremilast
(Otezla (TN)) 💬 | 4件: PDE4A PDE4A, PDE4B, PDE4C, PDE4D 💬 | 5件: Metabolic pathways Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬 | 1件: 271 271 💬 |
16 | Apremilast tablet 30 mg BID (Otezla (TN)) | 1件: Apremilast Apremilast (Otezla) | 1件: Apremilast
Apremilast
(Otezla (TN)) 💬 | 4件: PDE4A PDE4A, PDE4B, PDE4C, PDE4D 💬 | 5件: Metabolic pathways Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬 | 1件: 271 271 💬 |
17 | AZATHIOPRINE or METHOTREXATE (Otrexup (TN)) | 2件: Azathioprine Azathioprine, Methotrexate (Otrexup) | 2件: Methotrexate
Methotrexate
(Otrexup (TN)),
Azathioprine
💬 | 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 96 96 💬 |
18 | BARICITINIB (OTHER BARICITINIB) | 1件: Baricitinib Baricitinib | 1件: Baricitinib
Baricitinib
(OTHER BARICITINIB) 💬 | 2件: JAK1 JAK1, JAK2 💬 | 35件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | 13件: 2 2, 41, 46, 49, 50, 51, 53, 93, 107, 162, 265, 269, 325 💬 |
19 | Baricitinib 2 MG (OTHER BARICITINIB) | 1件: Baricitinib Baricitinib | 1件: Baricitinib
Baricitinib
(OTHER BARICITINIB) 💬 | 2件: JAK1 JAK1, JAK2 💬 | 35件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | 2件: 46 46, 53 💬 |
20 | Baricitinib 2 MG [Olumiant] (OTHER BARICITINIB) | 1件: Baricitinib Baricitinib | 1件: Baricitinib
Baricitinib
(OTHER BARICITINIB) 💬 | 2件: JAK1 JAK1, JAK2 💬 | 35件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | 1件: 162 162 💬 |
21 | Baricitinib 4 MG (OTHER BARICITINIB) | 1件: Baricitinib Baricitinib | 1件: Baricitinib
Baricitinib
(OTHER BARICITINIB) 💬 | 2件: JAK1 JAK1, JAK2 💬 | 35件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | 1件: 46 46 💬 |
22 | Baricitinib treatment (OTHER BARICITINIB) | 1件: Baricitinib Baricitinib | 1件: Baricitinib
Baricitinib
(OTHER BARICITINIB) 💬 | 2件: JAK1 JAK1, JAK2 💬 | 35件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | 1件: 46 46 💬 |
23 | Baricitinib, olumiant® (OTHER BARICITINIB) | 1件: Baricitinib Baricitinib | 1件: Baricitinib
Baricitinib
(OTHER BARICITINIB) 💬 | 2件: JAK1 JAK1, JAK2 💬 | 35件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | 1件: 46 46 💬 |
24 | BMN 110 - Every Other Week | - | - | - | - | 1件: 19 19 💬 |
25 | BMN 110 Every Other Week | - | - | - | - | 1件: 19 19 💬 |
26 | BMS-582949 and Methotrexate (Otrexup (TN)) | 2件: BMS-582949 BMS-582949, Methotrexate (Otrexup) | 1件: Methotrexate
Methotrexate
(Otrexup (TN)) 💬 | 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 💬 |
27 | Bromocriptine and other dopamine agonists | 2件: Bromocriptine Bromocriptine, Dopamine | 2件: Bromocriptine
Bromocriptine
,
Dopamine
💬 | 6件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5, PRL 💬 | 15件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, JAK-STAT signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬 |
28 | Busulfan/Fludarabine phosphate/Tacrolimus/Methotrexate/G-CSF (Otrexup (TN)) | 6件: Busulfan Busulfan, Filgrastim, Fludarabine, Methotrexate (Otrexup), Phosphate ion, Tacrolimus | 6件: Tacrolimus
Tacrolimus
,
Methotrexate
(Otrexup (TN)),
Busulfan
,
Filgrastim
,
Fludarabine
,
Tacrolimus
💬 | 9件: CSF3R CSF3R, DHFR, DHFR2, PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2, RRM1 💬 | 48件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Antifolate resistance, Axon guidance, B cell receptor signaling pathway, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Drug metabolism - other enzymes, Folate biosynthesis, Glucagon signaling pathway, Glutamatergic synapse, Glutathione metabolism, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Metabolic pathways, Natural killer cell mediated cytotoxicity, Nucleotide metabolism, One carbon pool by folate, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Purine metabolism, Pyrimidine metabolism, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 60 60 💬 |
29 | Certolizumab Pegol + Methotrexate (MTX) (Otrexup (TN)) | 2件: Certolizumab pegol Certolizumab pegol, Methotrexate (Otrexup) | 2件: Methotrexate
Methotrexate
(Otrexup (TN)),
Certolizumab pegol
💬 | 3件: DHFR DHFR, DHFR2, TNF 💬 | 71件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Metabolic pathways, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 💬 |
30 | Cipro (Ciprofloxacin, BAYQ3939) (Otiprio (TN)) | 1件: Ciprofloxacin Ciprofloxacin (Otiprio) | 1件: Ciprofloxacin
Ciprofloxacin
(Otiprio (TN)) 💬 | - | - | 1件: 299 299 💬 |
31 | Ciprofloxacin (Otiprio (TN)) | 1件: Ciprofloxacin Ciprofloxacin (Otiprio) | 1件: Ciprofloxacin
Ciprofloxacin
(Otiprio (TN)) 💬 | - | - | 5件: 2 2, 60, 96, 97, 299 💬 |
32 | Ciprofloxacin (BAYQ3939) dry powder for inhalation (Otiprio (TN)) | 1件: Ciprofloxacin Ciprofloxacin (Otiprio) | 1件: Ciprofloxacin
Ciprofloxacin
(Otiprio (TN)) 💬 | - | - | 1件: 299 299 💬 |
33 | Ciprofloxacin (Cipro Inhale, BAYQ3939) (Otiprio (TN)) | 1件: Ciprofloxacin Ciprofloxacin (Otiprio) | 1件: Ciprofloxacin
Ciprofloxacin
(Otiprio (TN)) 💬 | - | - | 1件: 299 299 💬 |
34 | Ciprofloxacin (Cipro, BAYQ3939) (Otiprio (TN)) | 1件: Ciprofloxacin Ciprofloxacin (Otiprio) | 1件: Ciprofloxacin
Ciprofloxacin
(Otiprio (TN)) 💬 | - | - | 1件: 299 299 💬 |
35 | Ciprofloxacin (ciproxin) (Otiprio (TN)) | 1件: Ciprofloxacin Ciprofloxacin (Otiprio) | 1件: Ciprofloxacin
Ciprofloxacin
(Otiprio (TN)) 💬 | - | - | 1件: 299 299 💬 |
36 | Ciprofloxacin dispersion for inhalation (Otiprio (TN)) | 1件: Ciprofloxacin Ciprofloxacin (Otiprio) | 1件: Ciprofloxacin
Ciprofloxacin
(Otiprio (TN)) 💬 | - | - | 1件: 299 299 💬 |
37 | Ciprofloxacin DPI (Otiprio (TN)) | 1件: Ciprofloxacin Ciprofloxacin (Otiprio) | 1件: Ciprofloxacin
Ciprofloxacin
(Otiprio (TN)) 💬 | - | - | 1件: 299 299 💬 |
38 | Ciprofloxacin DPI (BAYQ3939) (Otiprio (TN)) | 1件: Ciprofloxacin Ciprofloxacin (Otiprio) | 1件: Ciprofloxacin
Ciprofloxacin
(Otiprio (TN)) 💬 | - | - | 1件: 299 299 💬 |
39 | Ciprofloxacin for Inhalation (Otiprio (TN)) | 1件: Ciprofloxacin Ciprofloxacin (Otiprio) | 1件: Ciprofloxacin
Ciprofloxacin
(Otiprio (TN)) 💬 | - | - | 1件: 299 299 💬 |
40 | CIPROFLOXACIN HYDROCHLORIDE (Otiprio (TN)) | 1件: Ciprofloxacin Ciprofloxacin (Otiprio) | 1件: Ciprofloxacin
Ciprofloxacin
(Otiprio (TN)) 💬 | - | - | 2件: 96 96, 299 💬 |
41 | CIPROFLOXACIN HYDROCHLORIDE MONOHYDRATE (Otiprio (TN)) | 1件: Ciprofloxacin Ciprofloxacin (Otiprio) | 1件: Ciprofloxacin
Ciprofloxacin
(Otiprio (TN)) 💬 | - | - | 1件: 299 299 💬 |
42 | Ciprofloxacin Inhale (Otiprio (TN)) | 1件: Ciprofloxacin Ciprofloxacin (Otiprio) | 1件: Ciprofloxacin
Ciprofloxacin
(Otiprio (TN)) 💬 | - | - | 1件: 299 299 💬 |
43 | Clobetasol propionate + Methotrexate (Otrexup (TN)) | 3件: Clobetasol Clobetasol, Clobetasol propionate, Methotrexate (Otrexup) | 3件: Methotrexate
Methotrexate
(Otrexup (TN)),
Clobetasol propionate
,
Clobetasol
💬 | 3件: DHFR DHFR, DHFR2, NR3C1 💬 | 6件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, Neuroactive ligand-receptor interaction, One carbon pool by folate 💬 | 1件: 162 162 💬 |
44 | Combination Product: Exercise, and methotrexate (Otrexup (TN)) | 1件: Methotrexate Methotrexate (Otrexup) | 1件: Methotrexate
Methotrexate
(Otrexup (TN)) 💬 | 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 💬 |
45 | Combination Product: Laser, exercise, and methotrexate (Otrexup (TN)) | 1件: Methotrexate Methotrexate (Otrexup) | 1件: Methotrexate
Methotrexate
(Otrexup (TN)) 💬 | 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 💬 |
46 | Combination Product: Methotrexate (Otrexup (TN)) | 1件: Methotrexate Methotrexate (Otrexup) | 1件: Methotrexate
Methotrexate
(Otrexup (TN)) 💬 | 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 💬 |
47 | CP-690,550 + methotrexate (Otrexup (TN)) | 1件: Methotrexate Methotrexate (Otrexup) | 1件: Methotrexate
Methotrexate
(Otrexup (TN)) 💬 | 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 💬 |
48 | Cyclophosphamide followed by methotrexate (azathioprine) + glucocorticoids or methotrexate (azathioprine) + glucocorticoids (Otrexup (TN)) | 3件: Azathioprine Azathioprine, Cyclophosphamide, Methotrexate (Otrexup) | 4件: Methotrexate
Methotrexate
(Otrexup (TN)),
Azathioprine
,
Cyclophosphamide
,
Cyclophosphamide
💬 | 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 44 44 💬 |
49 | Cyclosporin, Methotrexate (GVHD prophylaxis) (Otrexup (TN)) | 2件: Cyclosporine Cyclosporine, Methotrexate (Otrexup) | 2件: Methotrexate
Methotrexate
(Otrexup (TN)),
Cyclosporine
💬 | 7件: DHFR DHFR, DHFR2, PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | 38件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Antifolate resistance, Axon guidance, B cell receptor signaling pathway, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Folate biosynthesis, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Metabolic pathways, Natural killer cell mediated cytotoxicity, One carbon pool by folate, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 326 326 💬 |
50 | DMARDs (methotrexate (Otrexup (TN)) | 1件: Methotrexate Methotrexate (Otrexup) | 1件: Methotrexate
Methotrexate
(Otrexup (TN)) 💬 | 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 💬 |
51 | Doxorubicin, methotrexate, cyclophosphamide, L-asparaginase (Otrexup (TN)) | 4件: Asparaginase Escherichia coli Asparaginase Escherichia coli, Cyclophosphamide, Doxorubicin, Methotrexate (Otrexup) | 4件: Methotrexate
Methotrexate
(Otrexup (TN)),
Cyclophosphamide
,
Doxorubicin
,
Cyclophosphamide
💬 | 4件: DHFR DHFR, DHFR2, TOP2A, TOP2B 💬 | 6件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate, Platinum drug resistance 💬 | 1件: 65 65 💬 |
52 | Early immunosuppressants (azathioprine, methotrexate) (Otrexup (TN)) | 2件: Azathioprine Azathioprine, Methotrexate (Otrexup) | 2件: Methotrexate
Methotrexate
(Otrexup (TN)),
Azathioprine
💬 | 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 96 96 💬 |
53 | Enalapril and other angiotensin converting enzyme inhibitors | 2件: Angiotensin II Angiotensin II, Enalapril | 3件: Angiotensin II
Angiotensin II
,
Angiotensin II
,
Enalapril
💬 | 3件: ACE ACE, AGTR1, AGTR2 💬 | 18件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 19 19 💬 |
54 | Etanercept + Methotrexate (Otrexup (TN)) | 2件: Etanercept Etanercept, Methotrexate (Otrexup) | 2件: Methotrexate
Methotrexate
(Otrexup (TN)),
Etanercept
💬 | 4件: DHFR DHFR, DHFR2, LTA, TNF 💬 | 71件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Metabolic pathways, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 💬 |
55 | Etanercept , Methotrexate (Otrexup (TN)) | 2件: Etanercept Etanercept, Methotrexate (Otrexup) | 2件: Methotrexate
Methotrexate
(Otrexup (TN)),
Etanercept
💬 | 4件: DHFR DHFR, DHFR2, LTA, TNF 💬 | 71件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Metabolic pathways, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 💬 |
56 | Etanercept, methotrexate and depomedrone (Otrexup (TN)) | 2件: Etanercept Etanercept, Methotrexate (Otrexup) | 2件: Methotrexate
Methotrexate
(Otrexup (TN)),
Etanercept
💬 | 4件: DHFR DHFR, DHFR2, LTA, TNF 💬 | 71件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Metabolic pathways, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 💬 |
57 | Etanercept, Methotrexate, Prednisolone (Otrexup (TN)) | 3件: Etanercept Etanercept, Methotrexate (Otrexup), Prednisolone | 3件: Methotrexate
Methotrexate
(Otrexup (TN)),
Prednisolone
,
Etanercept
💬 | 5件: DHFR DHFR, DHFR2, LTA, NR3C1, TNF 💬 | 72件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Metabolic pathways, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 56 56 💬 |
58 | Etanercept, other Biologics, Disease-modifying antirheumatic drugs (DMARDs), etc | 1件: Etanercept Etanercept | 1件: Etanercept
Etanercept
💬 | 2件: LTA LTA, TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 💬 |
59 | Ethylmethylcarbamic acid 3-[(1S)-1-(dimethylamino)ethyl]phenyl ester (**See other 2 names below) | - | - | - | - | 1件: 6 6 💬 |
60 | Ezetimibe + other lipid-lowering medication(s) | 1件: Ezetimibe Ezetimibe | 1件: Ezetimibe
Ezetimibe
💬 | 1件: NPC1L1 NPC1L1 💬 | 1件: Fat digestion and absorption Fat digestion and absorption 💬 | 1件: 260 260 💬 |
61 | Fixed dose combination Ciprofloxacin/Celecoxib (Otiprio (TN)) | 2件: Celecoxib Celecoxib, Ciprofloxacin (Otiprio) | 2件: Ciprofloxacin
Ciprofloxacin
(Otiprio (TN)),
Celecoxib
💬 | 1件: PTGS2 PTGS2 💬 | 22件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 2 2 💬 |
62 | Fluocinolone Acetonide (FLAC OTIC OIL) | 2件: Fluocinolone Fluocinolone, Fluocinolone acetonide (Otovel) | 1件: Fluocinolone acetonide
Fluocinolone acetonide
(FLAC OTIC OIL) 💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 90 90 💬 |
63 | GSK3196165 (Otilimab) | 1件: Otilimab Otilimab | 1件: Otilimab
Otilimab
💬 | 1件: CSF2 CSF2 💬 | 16件: Acute myeloid leukemia Acute myeloid leukemia, Amoebiasis, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, IL-17 signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Natural killer cell mediated cytotoxicity, Rheumatoid arthritis, Shigellosis, T cell receptor signaling pathway, TNF signaling pathway, Transcriptional misregulation in cancer 💬 | 1件: 46 46 💬 |
64 | Immunosuppressive regime (azathioprine, mycophenolate mofetil or methotrexate) (Otrexup (TN)) | 4件: Azathioprine Azathioprine, Methotrexate (Otrexup), Mycophenolate mofetil, Mycophenolic acid | 4件: Methotrexate
Methotrexate
(Otrexup (TN)),
Azathioprine
,
Mycophenolate mofetil
,
Mycophenolic acid
💬 | 4件: DHFR DHFR, DHFR2, IMPDH1, IMPDH2 💬 | 8件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Drug metabolism - other enzymes, Folate biosynthesis, Metabolic pathways, Nucleotide metabolism, One carbon pool by folate, Purine metabolism 💬 | 1件: 49 49 💬 |
65 | Infliximab + methotrexate (MTX) (Otrexup (TN)) | 2件: Infliximab Infliximab, Methotrexate (Otrexup) | 2件: Methotrexate
Methotrexate
(Otrexup (TN)),
Infliximab
💬 | 3件: DHFR DHFR, DHFR2, TNF 💬 | 71件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Metabolic pathways, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 💬 |
66 | Infliximab plus methotrexate (Otrexup (TN)) | 2件: Infliximab Infliximab, Methotrexate (Otrexup) | 2件: Methotrexate
Methotrexate
(Otrexup (TN)),
Infliximab
💬 | 3件: DHFR DHFR, DHFR2, TNF 💬 | 71件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Metabolic pathways, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 107 107 💬 |
67 | Infliximab, methylprednisolone, methotrexate (Otrexup (TN)) | 3件: Infliximab Infliximab, Methotrexate (Otrexup), Methylprednisolone | 3件: Methotrexate
Methotrexate
(Otrexup (TN)),
Methylprednisolone
,
Infliximab
💬 | 4件: DHFR DHFR, DHFR2, NR3C1, TNF 💬 | 72件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Metabolic pathways, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 💬 |
68 | Infusion of autologous cryopreserved EFS-ADA LV CD34+ cells (OTL-101) | - | - | - | - | 1件: 65 65 💬 |
69 | Intrathecal methotrexate (Otrexup (TN)) | 1件: Methotrexate Methotrexate (Otrexup) | 1件: Methotrexate
Methotrexate
(Otrexup (TN)) 💬 | 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 13 13 💬 |
70 | L01X - Other antineoplastic agents | - | - | - | - | 1件: 85 85 💬 |
71 | Losartan and other angiotensin receptor blockers | 2件: Angiotensin II Angiotensin II, Losartan | 3件: Angiotensin II
Angiotensin II
,
Angiotensin II
,
Losartan
💬 | 2件: AGTR1 AGTR1, AGTR2 💬 | 16件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 19 19 💬 |
72 | M2951 (Other Name: Evobrutinib) | 1件: Evobrutinib Evobrutinib | 1件: Evobrutinib
Evobrutinib
💬 | 1件: BTK BTK 💬 | 7件: B cell receptor signaling pathway B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬 | 1件: 49 49 💬 |
73 | METHOTREXATE (Otrexup (TN)) | 1件: Methotrexate Methotrexate (Otrexup) | 1件: Methotrexate
Methotrexate
(Otrexup (TN)) 💬 | 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 38件: 11 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 270, 271, 283, 284, 285, 286, 326, 331 💬 |
74 | Methotrexate 'Lederle' 2,5mg tablets (Otrexup (TN)) | 1件: Methotrexate Methotrexate (Otrexup) | 1件: Methotrexate
Methotrexate
(Otrexup (TN)) 💬 | 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 💬 |
75 | Methotrexate 'Lederle' 2.5mg Tablets (Otrexup (TN)) | 1件: Methotrexate Methotrexate (Otrexup) | 1件: Methotrexate
Methotrexate
(Otrexup (TN)) 💬 | 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 💬 |
76 | Methotrexate 'Lederle' Tablets (Otrexup (TN)) | 1件: Methotrexate Methotrexate (Otrexup) | 1件: Methotrexate
Methotrexate
(Otrexup (TN)) 💬 | 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 💬 |
77 | Methotrexate (Metoject® prefilled pen) (Otrexup (TN)) | 1件: Methotrexate Methotrexate (Otrexup) | 1件: Methotrexate
Methotrexate
(Otrexup (TN)) 💬 | 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 💬 |
78 | Methotrexate (MTX) (Otrexup (TN)) | 1件: Methotrexate Methotrexate (Otrexup) | 1件: Methotrexate
Methotrexate
(Otrexup (TN)) 💬 | 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 💬 |
79 | Methotrexate (stable dose) (Otrexup (TN)) | 1件: Methotrexate Methotrexate (Otrexup) | 1件: Methotrexate
Methotrexate
(Otrexup (TN)) 💬 | 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 💬 |
80 | Methotrexate (tapering dose) (Otrexup (TN)) | 1件: Methotrexate Methotrexate (Otrexup) | 1件: Methotrexate
Methotrexate
(Otrexup (TN)) 💬 | 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 💬 |
81 | Methotrexate + Infliximab (Otrexup (TN)) | 2件: Infliximab Infliximab, Methotrexate (Otrexup) | 2件: Methotrexate
Methotrexate
(Otrexup (TN)),
Infliximab
💬 | 3件: DHFR DHFR, DHFR2, TNF 💬 | 71件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Metabolic pathways, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 💬 |
82 | Methotrexate + Methylprednisolone (Otrexup (TN)) | 2件: Methotrexate Methotrexate (Otrexup), Methylprednisolone | 2件: Methotrexate
Methotrexate
(Otrexup (TN)),
Methylprednisolone
💬 | 3件: DHFR DHFR, DHFR2, NR3C1 💬 | 6件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, Neuroactive ligand-receptor interaction, One carbon pool by folate 💬 | 1件: 46 46 💬 |
83 | METHOTREXATE - 20 MG/0.8 ML SOLUZIONE INIETTABILE 4 SIRINGHE PRERIEMPITE MONOUSO DA 1.25 ML (Otrexup (TN)) | 1件: Methotrexate Methotrexate (Otrexup) | 1件: Methotrexate
Methotrexate
(Otrexup (TN)) 💬 | 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 96 96 💬 |
84 | Methotrexate - Amneal (Otrexup (TN)) | 1件: Methotrexate Methotrexate (Otrexup) | 1件: Methotrexate
Methotrexate
(Otrexup (TN)) 💬 | 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 💬 |
85 | Methotrexate - DAVA (Otrexup (TN)) | 1件: Methotrexate Methotrexate (Otrexup) | 1件: Methotrexate
Methotrexate
(Otrexup (TN)) 💬 | 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 💬 |
86 | Methotrexate - Delay (Otrexup (TN)) | 1件: Methotrexate Methotrexate (Otrexup) | 1件: Methotrexate
Methotrexate
(Otrexup (TN)) 💬 | 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 💬 |
87 | Methotrexate - etanercept - prednisolone arm (Otrexup (TN)) | 3件: Etanercept Etanercept, Methotrexate (Otrexup), Prednisolone | 3件: Methotrexate
Methotrexate
(Otrexup (TN)),
Prednisolone
,
Etanercept
💬 | 5件: DHFR DHFR, DHFR2, LTA, NR3C1, TNF 💬 | 72件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Metabolic pathways, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 2件: 46 46, 107 💬 |
88 | Methotrexate - Immediate (Otrexup (TN)) | 1件: Methotrexate Methotrexate (Otrexup) | 1件: Methotrexate
Methotrexate
(Otrexup (TN)) 💬 | 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 💬 |
89 | Methotrexate 10 mg (Otrexup (TN)) | 1件: Methotrexate Methotrexate (Otrexup) | 1件: Methotrexate
Methotrexate
(Otrexup (TN)) 💬 | 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 💬 |
90 | Methotrexate 10 mg tablets (Otrexup (TN)) | 1件: Methotrexate Methotrexate (Otrexup) | 1件: Methotrexate
Methotrexate
(Otrexup (TN)) 💬 | 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 💬 |
91 | Methotrexate 2.5 mg (Otrexup (TN)) | 1件: Methotrexate Methotrexate (Otrexup) | 1件: Methotrexate
Methotrexate
(Otrexup (TN)) 💬 | 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 44 44 💬 |
92 | METHOTREXATE 2.5 mg tablets (Otrexup (TN)) | 1件: Methotrexate Methotrexate (Otrexup) | 1件: Methotrexate
Methotrexate
(Otrexup (TN)) 💬 | 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 💬 |
93 | Methotrexate 2.5mg Tablets (Otrexup (TN)) | 1件: Methotrexate Methotrexate (Otrexup) | 1件: Methotrexate
Methotrexate
(Otrexup (TN)) 💬 | 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 💬 |
94 | Methotrexate 2.5mg Tablets BP (Otrexup (TN)) | 1件: Methotrexate Methotrexate (Otrexup) | 1件: Methotrexate
Methotrexate
(Otrexup (TN)) 💬 | 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 💬 |
95 | Methotrexate 25 mg (Otrexup (TN)) | 1件: Methotrexate Methotrexate (Otrexup) | 1件: Methotrexate
Methotrexate
(Otrexup (TN)) 💬 | 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 44 44 💬 |
96 | Methotrexate 50mg/ml solution for injection, pre-filled syringe (Otrexup (TN)) | 1件: Methotrexate Methotrexate (Otrexup) | 1件: Methotrexate
Methotrexate
(Otrexup (TN)) 💬 | 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 💬 |
97 | Methotrexate ``Lederle`` 2.5mg tablets (Otrexup (TN)) | 1件: Methotrexate Methotrexate (Otrexup) | 1件: Methotrexate
Methotrexate
(Otrexup (TN)) 💬 | 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 💬 |
98 | Methotrexate alone (Otrexup (TN)) | 1件: Methotrexate Methotrexate (Otrexup) | 1件: Methotrexate
Methotrexate
(Otrexup (TN)) 💬 | 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 107 107 💬 |
99 | Methotrexate and folic acid (Otrexup (TN)) | 2件: Folic acid Folic acid, Methotrexate (Otrexup) | 2件: Folic acid
Folic acid
,
Methotrexate
(Otrexup (TN)) 💬 | 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 49 49 💬 |
100 | Methotrexate as methotrexate disodium (Otrexup (TN)) | 1件: Methotrexate Methotrexate (Otrexup) | 1件: Methotrexate
Methotrexate
(Otrexup (TN)) 💬 | 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 💬 |
101 | Methotrexate bellon (Otrexup (TN)) | 1件: Methotrexate Methotrexate (Otrexup) | 1件: Methotrexate
Methotrexate
(Otrexup (TN)) 💬 | 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 97 97 💬 |
102 | Methotrexate bellon 25mg/ml (Otrexup (TN)) | 1件: Methotrexate Methotrexate (Otrexup) | 1件: Methotrexate
Methotrexate
(Otrexup (TN)) 💬 | 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 97 97 💬 |
103 | Methotrexate capsules (Otrexup (TN)) | 1件: Methotrexate Methotrexate (Otrexup) | 1件: Methotrexate
Methotrexate
(Otrexup (TN)) 💬 | 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 💬 |
104 | METHOTREXATE DISODIUM (Otrexup (TN)) | 1件: Methotrexate Methotrexate (Otrexup) | 1件: Methotrexate
Methotrexate
(Otrexup (TN)) 💬 | 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 5件: 46 46, 96, 97, 107, 271 💬 |
105 | Methotrexate Ebewe (Otrexup (TN)) | 1件: Methotrexate Methotrexate (Otrexup) | 1件: Methotrexate
Methotrexate
(Otrexup (TN)) 💬 | 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 💬 |
106 | METHOTREXATE HOSPIRA 2,5 mg tablety (Otrexup (TN)) | 1件: Methotrexate Methotrexate (Otrexup) | 1件: Methotrexate
Methotrexate
(Otrexup (TN)) 💬 | 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 💬 |
107 | METHOTREXATE HOSPIRA 2.5 mg tablety (Otrexup (TN)) | 1件: Methotrexate Methotrexate (Otrexup) | 1件: Methotrexate
Methotrexate
(Otrexup (TN)) 💬 | 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 💬 |
108 | Methotrexate injection (Otrexup (TN)) | 1件: Methotrexate Methotrexate (Otrexup) | 1件: Methotrexate
Methotrexate
(Otrexup (TN)) 💬 | 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 2件: 96 96, 97 💬 |
109 | Methotrexate Lachema 5inj. sol (Otrexup (TN)) | 1件: Methotrexate Methotrexate (Otrexup) | 1件: Methotrexate
Methotrexate
(Otrexup (TN)) 💬 | 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 50 50 💬 |
110 | Methotrexate Lederle 2.5 mg Tablets (Otrexup (TN)) | 1件: Methotrexate Methotrexate (Otrexup) | 1件: Methotrexate
Methotrexate
(Otrexup (TN)) 💬 | 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 💬 |
111 | Methotrexate Pfizer 2,5 mg tabletter (Otrexup (TN)) | 1件: Methotrexate Methotrexate (Otrexup) | 1件: Methotrexate
Methotrexate
(Otrexup (TN)) 💬 | 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 💬 |
112 | Methotrexate Placebo (Otrexup (TN)) | 1件: Methotrexate Methotrexate (Otrexup) | 1件: Methotrexate
Methotrexate
(Otrexup (TN)) 💬 | 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 💬 |
113 | Methotrexate plus ENBREL or ENBREL alone (Otrexup (TN)) | 1件: Methotrexate Methotrexate (Otrexup) | 1件: Methotrexate
Methotrexate
(Otrexup (TN)) 💬 | 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 💬 |
114 | Methotrexate plus ERB-041 for 12 weeks (Otrexup (TN)) | 1件: Methotrexate Methotrexate (Otrexup) | 1件: Methotrexate
Methotrexate
(Otrexup (TN)) 💬 | 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 💬 |
115 | Methotrexate plus sulfasalazine (Otrexup (TN)) | 2件: Methotrexate Methotrexate (Otrexup), Sulfasalazine | 2件: Methotrexate
Methotrexate
(Otrexup (TN)),
Sulfasalazine
💬 | 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 💬 |
116 | Methotrexate pre-filled pen (Otrexup (TN)) | 1件: Methotrexate Methotrexate (Otrexup) | 1件: Methotrexate
Methotrexate
(Otrexup (TN)) 💬 | 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 💬 |
117 | Methotrexate prefilled pen (Otrexup (TN)) | 1件: Methotrexate Methotrexate (Otrexup) | 1件: Methotrexate
Methotrexate
(Otrexup (TN)) 💬 | 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 💬 |
118 | Methotrexate prefilled syringe (Otrexup (TN)) | 1件: Methotrexate Methotrexate (Otrexup) | 1件: Methotrexate
Methotrexate
(Otrexup (TN)) 💬 | 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 💬 |
119 | METHOTREXATE SODIUM (Otrexup (TN)) | 1件: Methotrexate Methotrexate (Otrexup) | 1件: Methotrexate
Methotrexate
(Otrexup (TN)) 💬 | 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 2件: 46 46, 256 💬 |
120 | Methotrexate Sodium 2.5mg Tablets (Otrexup (TN)) | 1件: Methotrexate Methotrexate (Otrexup) | 1件: Methotrexate
Methotrexate
(Otrexup (TN)) 💬 | 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 💬 |
121 | Methotrexate Sodium Tablets 2.5 mg (Otrexup (TN)) | 1件: Methotrexate Methotrexate (Otrexup) | 1件: Methotrexate
Methotrexate
(Otrexup (TN)) 💬 | 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 💬 |
122 | Methotrexate Sodium Tablets 2.5mg (Otrexup (TN)) | 1件: Methotrexate Methotrexate (Otrexup) | 1件: Methotrexate
Methotrexate
(Otrexup (TN)) 💬 | 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 💬 |
123 | Methotrexate Tablets (Otrexup (TN)) | 1件: Methotrexate Methotrexate (Otrexup) | 1件: Methotrexate
Methotrexate
(Otrexup (TN)) 💬 | 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 2件: 40 40, 46 💬 |
124 | Methotrexate tablets 2.5 mg (Otrexup (TN)) | 1件: Methotrexate Methotrexate (Otrexup) | 1件: Methotrexate
Methotrexate
(Otrexup (TN)) 💬 | 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 💬 |
125 | Methotrexate treatment (Otrexup (TN)) | 1件: Methotrexate Methotrexate (Otrexup) | 1件: Methotrexate
Methotrexate
(Otrexup (TN)) 💬 | 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 2件: 41 41, 46 💬 |
126 | Methotrexate Wyeth 2,5mg (Otrexup (TN)) | 1件: Methotrexate Methotrexate (Otrexup) | 1件: Methotrexate
Methotrexate
(Otrexup (TN)) 💬 | 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 50 50 💬 |
127 | Methotrexate Wyeth 2,5mg tbl. (Otrexup (TN)) | 1件: Methotrexate Methotrexate (Otrexup) | 1件: Methotrexate
Methotrexate
(Otrexup (TN)) 💬 | 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 50 50 💬 |
128 | Methotrexate ® 2.5mg Tablets (Otrexup (TN)) | 1件: Methotrexate Methotrexate (Otrexup) | 1件: Methotrexate
Methotrexate
(Otrexup (TN)) 💬 | 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 💬 |
129 | Methotrexate(MTX) (Otrexup (TN)) | 1件: Methotrexate Methotrexate (Otrexup) | 1件: Methotrexate
Methotrexate
(Otrexup (TN)) 💬 | 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 💬 |
130 | Methotrexate(MTX) administration is at the discretion of the rheumatologist and no tradename is fixed by the protocol (Otrexup (TN)) | 1件: Methotrexate Methotrexate (Otrexup) | 1件: Methotrexate
Methotrexate
(Otrexup (TN)) 💬 | 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 💬 |
131 | Methotrexate(MTX) administration is at the discretion of the rheumatologist and no tradename is fixed by the protocol. (Otrexup (TN)) | 1件: Methotrexate Methotrexate (Otrexup) | 1件: Methotrexate
Methotrexate
(Otrexup (TN)) 💬 | 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 💬 |
132 | Methotrexate(necessary) (Otrexup (TN)) | 1件: Methotrexate Methotrexate (Otrexup) | 1件: Methotrexate
Methotrexate
(Otrexup (TN)) 💬 | 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 💬 |
133 | METHOTREXATE*100CPR 2,5MG (Otrexup (TN)) | 1件: Methotrexate Methotrexate (Otrexup) | 1件: Methotrexate
Methotrexate
(Otrexup (TN)) 💬 | 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 💬 |
134 | METHOTREXATE*10MG/1,33ML 4S (Otrexup (TN)) | 1件: Methotrexate Methotrexate (Otrexup) | 1件: Methotrexate
Methotrexate
(Otrexup (TN)) 💬 | 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 💬 |
135 | METHOTREXATE*15MG/2ML 4SIR (Otrexup (TN)) | 1件: Methotrexate Methotrexate (Otrexup) | 1件: Methotrexate
Methotrexate
(Otrexup (TN)) 💬 | 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 💬 |
136 | METHOTREXATE*2,5MG 25CPR (Otrexup (TN)) | 1件: Methotrexate Methotrexate (Otrexup) | 1件: Methotrexate
Methotrexate
(Otrexup (TN)) 💬 | 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 💬 |
137 | METHOTREXATE*20MG/2,66ML 4S (Otrexup (TN)) | 1件: Methotrexate Methotrexate (Otrexup) | 1件: Methotrexate
Methotrexate
(Otrexup (TN)) 💬 | 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 💬 |
138 | METHOTREXATE*25CPR 2,5MG (Otrexup (TN)) | 1件: Methotrexate Methotrexate (Otrexup) | 1件: Methotrexate
Methotrexate
(Otrexup (TN)) 💬 | 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 2件: 46 46, 107 💬 |
139 | METHOTREXATE*7,5MG/ML 4SIR. (Otrexup (TN)) | 1件: Methotrexate Methotrexate (Otrexup) | 1件: Methotrexate
Methotrexate
(Otrexup (TN)) 💬 | 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 💬 |
140 | Methotrexate, Leucovorin and BMS-986142 (Otrexup (TN)) | 3件: BMS-986142 BMS-986142, Leucovorin, Methotrexate (Otrexup) | 3件: Methotrexate
Methotrexate
(Otrexup (TN)),
Folinic acid
,
Folinic acid calcium salt pentahydrate
💬 | 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 💬 |
141 | Methotrexate,Adalimumab (Otrexup (TN)) | 2件: Adalimumab Adalimumab, Methotrexate (Otrexup) | 2件: Methotrexate
Methotrexate
(Otrexup (TN)),
Adalimumab
💬 | 3件: DHFR DHFR, DHFR2, TNF 💬 | 71件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Metabolic pathways, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 💬 |
142 | Methotrexate-Lachema (Otrexup (TN)) | 1件: Methotrexate Methotrexate (Otrexup) | 1件: Methotrexate
Methotrexate
(Otrexup (TN)) 💬 | 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 💬 |
143 | Methotrexate-Sulfasalazine-Hydroxychloroquine (Otrexup (TN)) | 3件: Hydroxychloroquine Hydroxychloroquine, Methotrexate (Otrexup), Sulfasalazine | 3件: Methotrexate
Methotrexate
(Otrexup (TN)),
Sulfasalazine
,
Hydroxychloroquine
💬 | 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 💬 |
144 | Methotrexate® 2.5 mg tablets (Otrexup (TN)) | 1件: Methotrexate Methotrexate (Otrexup) | 1件: Methotrexate
Methotrexate
(Otrexup (TN)) 💬 | 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 💬 |
145 | Methylprednisolone (or other glucocorticoid) | 1件: Methylprednisolone Methylprednisolone | 1件: Methylprednisolone
Methylprednisolone
💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 43 43 💬 |
146 | Moderna COVID-19 Vaccine (OTHER MODERNA COVID-19 VACCINE) | 1件: Moderna COVID-19 Vaccine Moderna COVID-19 Vaccine | 1件: Elasomeran
Elasomeran
(OTHER MODERNA COVID-19 VACCINE) 💬 | - | - | 1件: 46 46 💬 |
147 | MP-435(dose1) + Methotrexate (Otrexup (TN)) | 1件: Methotrexate Methotrexate (Otrexup) | 1件: Methotrexate
Methotrexate
(Otrexup (TN)) 💬 | 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 💬 |
148 | MSDMDs other than Betaseron (Interferon beta-1b, BAY86-5046) | 2件: Human interferon beta Human interferon beta, Interferon beta-1b | 1件: Interferon beta-1b
Interferon beta-1b
💬 | 2件: IFNAR1 IFNAR1, IFNAR2 💬 | 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 💬 |
149 | Mycophenolate mofetil,methotrexate (Otrexup (TN)) | 3件: Methotrexate Methotrexate (Otrexup), Mycophenolate mofetil, Mycophenolic acid | 3件: Methotrexate
Methotrexate
(Otrexup (TN)),
Mycophenolate mofetil
,
Mycophenolic acid
💬 | 4件: DHFR DHFR, DHFR2, IMPDH1, IMPDH2 💬 | 8件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Drug metabolism - other enzymes, Folate biosynthesis, Metabolic pathways, Nucleotide metabolism, One carbon pool by folate, Purine metabolism 💬 | 3件: 42 42, 43, 45 💬 |
150 | Oral ciprofloxacin (Otiprio (TN)) | 1件: Ciprofloxacin Ciprofloxacin (Otiprio) | 1件: Ciprofloxacin
Ciprofloxacin
(Otiprio (TN)) 💬 | - | - | 1件: 299 299 💬 |
151 | Oral ciprofloxacin plus inhaled colistin (Otiprio (TN)) | 2件: Ciprofloxacin Ciprofloxacin (Otiprio), Colistin | 2件: Ciprofloxacin
Ciprofloxacin
(Otiprio (TN)),
Colistin
💬 | - | - | 1件: 299 299 💬 |
152 | Oral methotrexate (Otrexup (TN)) | 1件: Methotrexate Methotrexate (Otrexup) | 1件: Methotrexate
Methotrexate
(Otrexup (TN)) 💬 | 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 💬 |
153 | OT | - | - | - | - | 1件: 193 193 💬 |
154 | Otelixizumab | 1件: Otelixizumab Otelixizumab | 1件: Otelixizumab
Otelixizumab
💬 | 3件: CD3D CD3D, CD3E, CD3G 💬 | 11件: Chagas disease Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 | 1件: 46 46 💬 |
155 | Otezla | 1件: Apremilast Apremilast (Otezla) | 1件: Apremilast
Apremilast
(Otezla (TN)) 💬 | 4件: PDE4A PDE4A, PDE4B, PDE4C, PDE4D 💬 | 5件: Metabolic pathways Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬 | 3件: 56 56, 107, 162 💬 |
156 | OTEZLA - 10 MG + 20 MG + 30 MG COMPRESSA RIVESTITA CON FILM USO ORALE - BLISTER (PVC/ALU) IN UN ASTUCCIO - 4 COMPRESSE DA 10 MG + 4 COMPRESSE DA 20 MG +19 COMPRESSE DA 30 MG | 1件: Apremilast Apremilast (Otezla) | 1件: Apremilast
Apremilast
(Otezla (TN)) 💬 | 4件: PDE4A PDE4A, PDE4B, PDE4C, PDE4D 💬 | 5件: Metabolic pathways Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬 | 2件: 56 56, 107 💬 |
157 | OTEZLA - 30 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - BLISTER (PVC/ALU) - 56 COMPRESSE | 1件: Apremilast Apremilast (Otezla) | 1件: Apremilast
Apremilast
(Otezla (TN)) 💬 | 4件: PDE4A PDE4A, PDE4B, PDE4C, PDE4D 💬 | 5件: Metabolic pathways Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬 | 1件: 107 107 💬 |
158 | Other analgesics and antipyretics | - | - | - | - | 1件: 13 13 💬 |
159 | Other antiepileptics | - | - | - | - | 1件: 140 140 💬 |
160 | Other Biologic Therapies | - | - | - | - | 2件: 96 96, 97 💬 |
161 | Other biological agent | - | - | - | - | 2件: 46 46, 96 💬 |
162 | Other Biologics | - | - | - | - | 1件: 46 46 💬 |
163 | Other COX-2 inhibitor | - | - | - | - | 1件: 271 271 💬 |
164 | Other Cox-2 inhibitors | - | - | - | - | 1件: 271 271 💬 |
165 | Other Crystalloid | - | - | - | - | 1件: 296 296 💬 |
166 | Other disease-modifying therapy | - | - | - | - | 1件: 13 13 💬 |
167 | Other H1 antagonist | - | - | - | - | 1件: 13 13 💬 |
168 | Other hematological Agents | - | - | - | - | 1件: 65 65 💬 |
169 | OTHER NERVOUS SYSTEM DRUGS | - | - | - | - | 2件: 6 6, 13 💬 |
170 | Other Non Steroidal Anti-Inflammatory Drugs (NSAIDs) except etodolac | 1件: Etodolac Etodolac | 1件: Etodolac
Etodolac
💬 | 1件: PTGS2 PTGS2 💬 | 22件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 46 46 💬 |
171 | Other Non-selective NSAIDs | - | - | - | - | 1件: 271 271 💬 |
172 | Other non-sponsor pancreatic enzyme replacement therapy | - | - | - | - | 1件: 299 299 💬 |
173 | Other Parkinson's Disease treatments | - | - | - | - | 1件: 6 6 💬 |
174 | Other respiratory system products | - | - | - | - | 1件: 299 299 💬 |
175 | OTHER SOURCES | - | - | - | - | 1件: 228 228 💬 |
176 | Other vasodilator | - | - | - | - | 1件: 51 51 💬 |
177 | OTILIMAB | 1件: Otilimab Otilimab | 1件: Otilimab
Otilimab
💬 | 1件: CSF2 CSF2 💬 | 16件: Acute myeloid leukemia Acute myeloid leukemia, Amoebiasis, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, IL-17 signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Natural killer cell mediated cytotoxicity, Rheumatoid arthritis, Shigellosis, T cell receptor signaling pathway, TNF signaling pathway, Transcriptional misregulation in cancer 💬 | 1件: 46 46 💬 |
178 | Otilimab (GSK3196165) | 1件: Otilimab Otilimab | 1件: Otilimab
Otilimab
💬 | 1件: CSF2 CSF2 💬 | 16件: Acute myeloid leukemia Acute myeloid leukemia, Amoebiasis, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, IL-17 signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Natural killer cell mediated cytotoxicity, Rheumatoid arthritis, Shigellosis, T cell receptor signaling pathway, TNF signaling pathway, Transcriptional misregulation in cancer 💬 | 1件: 46 46 💬 |
179 | OTL-101 | - | - | - | - | 1件: 65 65 💬 |
180 | OTL-103 | - | - | - | - | 1件: 65 65 💬 |
181 | OTL-103 Dispersion for Infusion | - | - | - | - | 1件: 65 65 💬 |
182 | OTL-200 | - | - | - | - | 1件: 19 19 💬 |
183 | OTL-200 Dispersion for Infusion | - | - | - | - | 1件: 19 19 💬 |
184 | OTL-200 Gene Therapy | - | - | - | - | 1件: 19 19 💬 |
185 | OTL38 | - | - | - | - | 1件: 46 46 💬 |
186 | Phase 1: Methotrexate (Otrexup (TN)) | 1件: Methotrexate Methotrexate (Otrexup) | 1件: Methotrexate
Methotrexate
(Otrexup (TN)) 💬 | 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 💬 |
187 | PO ciprofloxacin (Otiprio (TN)) | 1件: Ciprofloxacin Ciprofloxacin (Otiprio) | 1件: Ciprofloxacin
Ciprofloxacin
(Otiprio (TN)) 💬 | - | - | 1件: 299 299 💬 |
188 | Response to anakinra associated with methotrexate (Otrexup (TN)) | 2件: Anakinra Anakinra, Methotrexate (Otrexup) | 2件: Methotrexate
Methotrexate
(Otrexup (TN)),
Anakinra
💬 | 4件: DHFR DHFR, DHFR2, IL1R1, IL1R2 💬 | 20件: Amoebiasis Amoebiasis, Antifolate resistance, Biosynthesis of cofactors, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Folate biosynthesis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, MAPK signaling pathway, Metabolic pathways, NF-kappa B signaling pathway, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Prostate cancer, Shigellosis, Th17 cell differentiation, Transcriptional misregulation in cancer 💬 | 1件: 46 46 💬 |
189 | Response to infliximab associated with methotrexate (Otrexup (TN)) | 2件: Infliximab Infliximab, Methotrexate (Otrexup) | 2件: Methotrexate
Methotrexate
(Otrexup (TN)),
Infliximab
💬 | 3件: DHFR DHFR, DHFR2, TNF 💬 | 71件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Metabolic pathways, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 💬 |
190 | Sedatives/Hypnotics,Other | - | - | - | - | 1件: 107 107 💬 |
191 | See D.3.9.3 'Other descriptive name' below | - | - | - | - | 1件: 46 46 💬 |
192 | Stable weekly dose of methotrexate (Otrexup (TN)) | 1件: Methotrexate Methotrexate (Otrexup) | 1件: Methotrexate
Methotrexate
(Otrexup (TN)) 💬 | 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 💬 |
193 | Tacrolimus with Methotrexate (Otrexup (TN)) | 2件: Methotrexate Methotrexate (Otrexup), Tacrolimus | 3件: Tacrolimus
Tacrolimus
,
Methotrexate
(Otrexup (TN)),
Tacrolimus
💬 | 7件: DHFR DHFR, DHFR2, PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | 38件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Antifolate resistance, Axon guidance, B cell receptor signaling pathway, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Folate biosynthesis, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Metabolic pathways, Natural killer cell mediated cytotoxicity, One carbon pool by folate, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 46 46 💬 |
194 | TAK-715 and methotrexate (Otrexup (TN)) | 2件: Methotrexate Methotrexate (Otrexup), TAK-715 | 1件: Methotrexate
Methotrexate
(Otrexup (TN)) 💬 | 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 💬 |
195 | TAK-783 and methotrexate (Otrexup (TN)) | 1件: Methotrexate Methotrexate (Otrexup) | 1件: Methotrexate
Methotrexate
(Otrexup (TN)) 💬 | 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 💬 |
196 | Tasocitinib plus Methotrexate (Otrexup (TN)) | 2件: Methotrexate Methotrexate (Otrexup), Tofacitinib | 2件: Methotrexate
Methotrexate
(Otrexup (TN)),
Tofacitinib
💬 | 6件: DHFR DHFR, DHFR2, JAK1, JAK2, JAK3, TYK2 💬 | 42件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Antifolate resistance, Biosynthesis of cofactors, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Folate biosynthesis, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, Metabolic pathways, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, One carbon pool by folate, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | 1件: 46 46 💬 |
197 | TNF-alpha antagonist and other biotherapy | - | - | - | - | 1件: 46 46 💬 |
198 | Tocilizumab + methotrexate(MTX) (Otrexup (TN)) | 2件: Methotrexate Methotrexate (Otrexup), Tocilizumab | 2件: Methotrexate
Methotrexate
(Otrexup (TN)),
Tocilizumab
💬 | 3件: DHFR DHFR, DHFR2, IL6R 💬 | 17件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Folate biosynthesis, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Metabolic pathways, Non-alcoholic fatty liver disease, One carbon pool by folate, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 1件: 46 46 💬 |
199 | Tocilizumab plus methotrexate (Otrexup (TN)) | 2件: Methotrexate Methotrexate (Otrexup), Tocilizumab | 2件: Methotrexate
Methotrexate
(Otrexup (TN)),
Tocilizumab
💬 | 3件: DHFR DHFR, DHFR2, IL6R 💬 | 17件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Folate biosynthesis, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Metabolic pathways, Non-alcoholic fatty liver disease, One carbon pool by folate, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 1件: 46 46 💬 |
200 | Tocilizumab+Methotrexate(MTX) (Otrexup (TN)) | 2件: Methotrexate Methotrexate (Otrexup), Tocilizumab | 2件: Methotrexate
Methotrexate
(Otrexup (TN)),
Tocilizumab
💬 | 3件: DHFR DHFR, DHFR2, IL6R 💬 | 17件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Folate biosynthesis, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Metabolic pathways, Non-alcoholic fatty liver disease, One carbon pool by folate, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 1件: 46 46 💬 |
201 | Tofacitinib or Baricitinib (OTHER BARICITINIB) | 2件: Baricitinib Baricitinib, Tofacitinib | 2件: Tofacitinib
Tofacitinib
,
Baricitinib
(OTHER BARICITINIB) 💬 | 4件: JAK1 JAK1, JAK2, JAK3, TYK2 💬 | 37件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | 1件: 46 46 💬 |
202 | Tofacitinib with methotrexate (Otrexup (TN)) | 2件: Methotrexate Methotrexate (Otrexup), Tofacitinib | 2件: Methotrexate
Methotrexate
(Otrexup (TN)),
Tofacitinib
💬 | 6件: DHFR DHFR, DHFR2, JAK1, JAK2, JAK3, TYK2 💬 | 42件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Antifolate resistance, Biosynthesis of cofactors, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Folate biosynthesis, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, Metabolic pathways, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, One carbon pool by folate, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | 1件: 46 46 💬 |
203 | Tofacitinib without methotrexate (Otrexup (TN)) | 2件: Methotrexate Methotrexate (Otrexup), Tofacitinib | 2件: Methotrexate
Methotrexate
(Otrexup (TN)),
Tofacitinib
💬 | 6件: DHFR DHFR, DHFR2, JAK1, JAK2, JAK3, TYK2 💬 | 42件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Antifolate resistance, Biosynthesis of cofactors, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Folate biosynthesis, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, Metabolic pathways, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, One carbon pool by folate, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | 1件: 46 46 💬 |
204 | Tofacitinib/baricitinib (OTHER BARICITINIB) | 2件: Baricitinib Baricitinib, Tofacitinib | 2件: Tofacitinib
Tofacitinib
,
Baricitinib
(OTHER BARICITINIB) 💬 | 4件: JAK1 JAK1, JAK2, JAK3, TYK2 💬 | 37件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | 1件: 46 46 💬 |
205 | Tozinameran (OTHER BNT162B2) | 1件: Tozinameran Tozinameran | 1件: Tozinameran
Tozinameran
(OTHER BNT162B2) 💬 | - | - | 1件: 299 299 💬 |
206 | Treatment with systemic therapy (methotrexate) (Otrexup (TN)) | 1件: Methotrexate Methotrexate (Otrexup) | 1件: Methotrexate
Methotrexate
(Otrexup (TN)) 💬 | 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 162 162 💬 |
207 | Urine samples taken to measure methotrexate and its major metabolite 7-OH-methotrexate level (Otrexup (TN)) | 1件: Methotrexate Methotrexate (Otrexup) | 1件: Methotrexate
Methotrexate
(Otrexup (TN)) 💬 | 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 💬 |